Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Veeva Systems Inc. Releases Strong 10-Q Report

Veeva Systems Inc. has recently released its 10-Q report, providing a detailed insight into the company's financial condition and operational performance. Veeva Systems Inc. offers cloud-based software for the life sciences industry across various regions. The company's offerings include Veeva Commercial Cloud, Veeva Data Cloud, Veeva Development Cloud, and Veeva Quality Cloud, catering to the unique needs of its customers in the life sciences industry.

In the 10-Q report, Veeva Systems Inc. highlighted its financial performance for the six months ended July 31, 2025. The company reported total revenues of $1,548,124, with subscription services accounting for $1,293,951 and professional services and other revenues totaling $254,173. The cost of revenues for this period amounted to $369,077, resulting in a gross profit of $1,179,047.

Operating expenses for the same period were $749,407, comprising research and development expenses of $376,710, sales and marketing expenses of $208,067, and general and administrative expenses of $164,630. Veeva Systems Inc. reported an operating income of $429,640.

The company's other income, net, stood at $134,545, leading to an income before income taxes of $564,185. After accounting for an income tax provision of $135,686, Veeva Systems Inc. reported a net income of $428,499 for the six months ended July 31, 2025.

These figures reflect Veeva Systems Inc.'s robust financial performance and its continued focus on providing industry cloud solutions for the global life sciences industry. The company's ability to generate significant revenues and maintain a strong customer base underscores its position as a leading provider in the industry. As a result of these announcements, the company's shares have moved -1.15% on the market, and are now trading at a price of $269.20. For more information, read the company's full 10-Q submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS